LRFN5 and OLFM4 as novel potential biomarkers for major depressive disorder: a pilot study
Abstract Evidences have shown that both LRFN5 and OLFM4 can regulate neural development and synaptic function. Recent genome-wide association studies on major depressive disorder (MDD) have implicated LRFN5 and OLFM4, but their expressions and roles in MDD are still completely unclear. Here, we exam...
Main Authors: | Ke Xu, Peng Zheng, Shuang Zhao, Jiubing Wang, Jinzhou Feng, Yi Ren, Qi Zhong, Hanping Zhang, Xiangyu Chen, Jianjun Chen, Peng Xie |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-06-01
|
Series: | Translational Psychiatry |
Online Access: | https://doi.org/10.1038/s41398-023-02490-7 |
Similar Items
-
New Insights of OLFM2 and OLFM4 in Gut-Liver Axis and Their Potential Involvement in Nonalcoholic Fatty Liver Disease
by: Laia Bertran, et al.
Published: (2022-07-01) -
Paneth-like cells produced from OLFM4+ stem cells support OLFM4+ stem cell growth in advanced colorectal cancer
by: Mizuho Sakahara, et al.
Published: (2024-01-01) -
MANF/EWSR1/ANXA6 pathway might as the bridge between hypolipidemia and major depressive disorder
by: Ke Xu, et al.
Published: (2022-12-01) -
Oral d-ribose causes depressive-like behavior by altering glycerophospholipid metabolism via the gut-brain axis
by: Ke Xu, et al.
Published: (2024-01-01) -
Dysregulation of erythropoiesis and altered erythroblastic NMDA receptor-mediated calcium influx in Lrfn2-deficient mice.
by: Ryuta Maekawa, et al.
Published: (2021-01-01)